433 related articles for article (PubMed ID: 15707734)
21. Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agent.
Parise A; Milelli A; Tumiatti V; Minarini A; Neviani P; Zuccari G
Drug Deliv; 2015; 22(5):590-7. PubMed ID: 24286206
[TBL] [Abstract][Full Text] [Related]
22. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
[TBL] [Abstract][Full Text] [Related]
23. [Freeze-drying of silymarin-loaded solid lipid nanoparticles (SM-SLN)].
He J; Feng JF; Zhang LL; Lu WG; Hou SX
Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(2):110-2. PubMed ID: 15714812
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery of an anti-cancer agent via steroid coupled liposomes.
Mishra PK; Gulbake A; Jain A; Vyas SP; Jain SK
Drug Deliv; 2009 Nov; 16(8):437-47. PubMed ID: 19839788
[TBL] [Abstract][Full Text] [Related]
25. [Freeze-drying of oleanolic acid-loaded nanosuspensions].
Zhao XL; Chen HB; Chen YJ; Yang XL
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1874-6. PubMed ID: 18051893
[TBL] [Abstract][Full Text] [Related]
26. [Preparation of cisplatin multivesicular liposomes and release of cisplatin from the liposomes in vitro].
Xiao CJ; Qi XR; Aini W; Wei SL
Yao Xue Xue Bao; 2003 Feb; 38(2):133-7. PubMed ID: 12778750
[TBL] [Abstract][Full Text] [Related]
27. [Study on preparation technology of aconitine liposomes].
Dong WW; Zhang YF; Liu XP; Geng DQ
Zhong Yao Cai; 2008 Sep; 31(9):1413-5. PubMed ID: 19180972
[TBL] [Abstract][Full Text] [Related]
28. Long-term stability of sterically stabilized liposomes by freezing and freeze-drying: Effects of cryoprotectants on structure.
Stark B; Pabst G; Prassl R
Eur J Pharm Sci; 2010 Nov; 41(3-4):546-55. PubMed ID: 20800680
[TBL] [Abstract][Full Text] [Related]
29. Application of different methods to formulate PEG-liposomes of oxaliplatin: evaluation in vitro and in vivo.
Zalba S; Navarro I; Trocóniz IF; Tros de Ilarduya C; Garrido MJ
Eur J Pharm Biopharm; 2012 Jun; 81(2):273-80. PubMed ID: 22369879
[TBL] [Abstract][Full Text] [Related]
30. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method.
Qiu L; Jing N; Jin Y
Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626
[TBL] [Abstract][Full Text] [Related]
31. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
[TBL] [Abstract][Full Text] [Related]
32. Size of thermosensitive liposomes influences content release.
Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
[TBL] [Abstract][Full Text] [Related]
33. Storage stability of stabilized MLV and REV liposomes containing sodium methotrexate (aqueous & lyophilized).
Sarbolouki MN; Toliat T
PDA J Pharm Sci Technol; 1998; 52(1):23-7. PubMed ID: 9542411
[TBL] [Abstract][Full Text] [Related]
34. Study of the pilot production process of long-circulating and pH-sensitive liposomes containing cisplatin.
dos Santos Giuberti C; de Oliveira Reis EC; Ribeiro Rocha TG; Leite EA; Lacerda RG; Ramaldes GA; de Oliveira MC
J Liposome Res; 2011 Mar; 21(1):60-9. PubMed ID: 20429813
[TBL] [Abstract][Full Text] [Related]
35. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design.
Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Dehkordi AJ; Kobarfard F
Pharm Dev Technol; 2012; 17(2):187-94. PubMed ID: 21047276
[TBL] [Abstract][Full Text] [Related]
36. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation, characterization, and in vitro/in vivo evaluation.
Mattheolabakis G; Nie T; Constantinides PP; Rigas B
Pharm Res; 2012 Jun; 29(6):1435-43. PubMed ID: 22072052
[TBL] [Abstract][Full Text] [Related]
37. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology.
Teeranachaideekul V; Junyaprasert VB; Souto EB; Müller RH
Int J Pharm; 2008 Apr; 354(1-2):227-34. PubMed ID: 18242898
[TBL] [Abstract][Full Text] [Related]
38. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
Jelvehgari M; Atapour F; Nokhodchi A
Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
[TBL] [Abstract][Full Text] [Related]
39. Proniosomes as drug carriers.
Sankar V; Ruckmani K; Durga S; Jailani S
Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
[TBL] [Abstract][Full Text] [Related]
40. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
